Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base
July 11, 2024
Illumina, a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology.